-
1121
Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
Published 2009-01-01“…We present two cases of patients without pre-existent liver disease treated with oxaliplatin-based chemotherapy followed by surgical resection of their CLMs. …”
Get full text
Article -
1122
Adipokines regulate the development and progression of MASLD through organellar oxidative stress
Published 2025-02-01“…The prevalence of metabolic dysfunction–associated steatotic liver disease (MASLD), which is increasingly being recognized as a leading cause of chronic liver pathology globally, is increasing. …”
Get full text
Article -
1123
Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients
Published 2013-01-01“…Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary vascular complications of liver disease. While HPS is characterized by low pulmonary vascular resistance, PPHTN is defined by the presence of elevated pulmonary vascular resistance. …”
Get full text
Article -
1124
Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy
Published 2021-01-01“…To investigate the risk of progression of the liver disease, liver stiffness (LS) and HBV-DNA were monitored over time. …”
Get full text
Article -
1125
Long-term Outcomes (10 years) of Hepatic Transplantation in a Patient with Hepatic Adenomatosis: A Case Report
Published 2024-12-01“…She had no significant medical history, chronic liver disease, or diabetes and was not taking any regular medications or anabolic steroids. …”
Get full text
Article -
1126
A patient with probable rare blood Group B(A) phenotype
Published 2024-12-01“…We here report a case of the B(A) phenotype in a patient who was diagnosed with chronic liver disease with acute pancreatitis, requiring packed red blood cells due to anemia. …”
Get full text
Article -
1127
Hepatitis C Virus–Pediatric and Adult Perspectives in the Current Decade
Published 2024-12-01“…Hepatitis C virus (HCV) infects both pediatric and adult populations and is an important cause of chronic liver disease worldwide. There are differences in the screening and management of HCV between pediatric and adult patients, which have been highlighted in this review. …”
Get full text
Article -
1128
Updates in Biliary Atresia: Aetiology, Diagnosis and Surgery
Published 2025-01-01“…Affected infants present with a triad of conjugated jaundice, pale stools, and dark urine and may have hepatosplenomegaly upon examination, with later ascites coincident with the onset of progressive liver disease. Rapid, efficient, and expeditious diagnosis is essential with the initial treatment being surgical, typically with an attempt to restore the bile flow (Kasai portoenterostomy (KPE)) or primary liver transplantation (<5%) if considered futile. …”
Get full text
Article -
1129
Effects of pesticide dichlorvos on liver injury in rats and related toxicity mechanisms
Published 2025-01-01“…Recent epidemiological studies suggest that exposure to DDVP correlates with an increased incidence of liver disease. However, data regarding the hepatotoxicity of DDVP remain limited. …”
Get full text
Article -
1130
Holotranscobalamin Is a Useful Marker of Vitamin B12 Deficiency in Alcoholics
Published 2012-01-01“…Falsely increased values of Cbl can be caused by alcoholic liver disease. Measurement of total vitamin B12 serum levels might be misleading in alcoholics, because a tissue metabolic deficiency is possible even with normal serum Cbl levels. …”
Get full text
Article -
1131
Autoimmune hepatitis: new in diagnostics, a pathogenesis and treatment
Published 2012-09-01“…AIH is a chronic inflammatory liver disease which is characterized by destruction of terminal plate by mononuclear infiltrate (interface hepatitis) according to histological investigation, hypergammaglobulinemia and production of autoantibodies. …”
Get full text
Article -
1132
The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood
Published 2016-01-01“…Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease characterized by chronic inflammation of the biliary tree resulting in liver fibrosis. …”
Get full text
Article -
1133
Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cells
Published 2025-01-01“…Abstract Liver fibrosis is a critical liver disease that can progress to more severe manifestations, such as cirrhosis, yet no effective targeted therapies are available. …”
Get full text
Article -
1134
Wilson’s Disease: Diagnosis of Wilson’s Disease in Ethiopian Young Sisters
Published 2020-01-01“…Both siblings had visible ocular Kayser–Fleischer rings, low serum ceruloplasmin level and increased urinary copper content, ultrasound-evidenced cirrhotic liver disease, and axial T2-weighted MRI hyperintensities in basal ganglia, thalamus, and brainstem (midbrain and pons). …”
Get full text
Article -
1135
Evaluation of the role of unconventional prefoldin RPB5 interactor (URI1) in hepatitis B virus infection
Published 2025-01-01“…Abstract Hepatitis B virus (HBV) infection can cause liver disease and lead to hepatocellular carcinoma (HCC). …”
Get full text
Article -
1136
Hepatocellular Carcinoma with Both Fibrolamellar and Classical Components: An Unusual Morphological Pattern
Published 2015-01-01“…It is usually seen in young adults without underlying liver disease. Histologically, it shows large cells with abundant eosinophilic cytoplasm, large vesicular nuclei, prominent nucleoli, and lamellar type fibrosis. …”
Get full text
Article -
1137
Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD
Published 2017-03-01“…Abstract To elucidate the molecular mechanisms underlying non‐alcoholic fatty liver disease (NAFLD), we recruited 86 subjects with varying degrees of hepatic steatosis (HS). …”
Get full text
Article -
1138
Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases
Published 2025-03-01“…Dysregulation of macrophage immunometabolism has been closely implicated in several metabolic diseases, including obesity, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), hypertension, atherosclerosis, and gout, which positions macrophages as potential therapeutic targets. …”
Get full text
Article -
1139
Meteorin-like alleviates hepatic steatosis by regulating hepatic triglyceride secretion and fatty acid oxidation
Published 2025-02-01“…Summary: Amid a rising prevalence of non-alcoholic fatty liver disease (NAFLD), there is still an unmet need to better treat it. …”
Get full text
Article -
1140
Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents
Published 2025-01-01“…This research monitored occurrences of virological relapse, hepatocellular carcinoma (HCC), mortality, and liver disease progression. The annualized incidence rates (AIRs), cumulative incidence rates of adverse events and risk factors were investigated. …”
Get full text
Article